Animal carcinogenicity studies: 3. Alternatives to the bioassay

Alternatives to Laboratory Animals : ATLA
Andrew KnightJonathan Balcombe

Abstract

Conventional animal carcinogenicity tests take around three years to design, conduct and interpret. Consequently, only a tiny fraction of the thousands of industrial chemicals currently in use have been tested for carcinogenicity. Despite the costs of hundreds of millions of dollars and millions of skilled personnel hours, as well as millions of animal lives, several investigations have revealed that animal carcinogenicity data lack human specificity (i.e. the ability to identify human non-carcinogens), which severely limits the human predictivity of the bioassay. This is due to the scientific inadequacies of many carcinogenicity bioassays, and numerous serious biological obstacles, which render profoundly difficult any attempts to accurately extrapolate animal data in order to predict carcinogenic hazards to humans. Proposed modifications to the conventional bioassays have included the elimination of mice as a second species, and the use of genetically-altered or neonatal mice, decreased study durations, initiation-promotion models, the greater incorporation of toxicokinetic and toxicodynamic assessments, structure-activity relationship (computerised) systems, in vitro assays, cDNA microarrays for detecting changes in gene exp...Continue Reading

References

Jul 1, 1995·Environmental Health Perspectives·V A FungJ Huff
Feb 1, 1996·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·A Monro
Feb 1, 1997·Regulatory Toxicology and Pharmacology : RTP·J P Van OosterhoutR Bass
May 20, 1998·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·A M Monro, J S MacDonald
Oct 27, 1998·American Journal of Industrial Medicine·M Karstadt
Mar 16, 2000·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·T S DaviesE R Nestmann
Apr 25, 2000·Drug Metabolism Reviews·D P Rall
Nov 7, 2001·Toxicologic Pathology·R M McClainJ Sagartz
Jul 27, 2002·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·A BesaratiniaF J Van Schooten
Oct 25, 2002·Teratology·Kimberly E Docterman, Susan M Smith
May 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Karol L Thompson, Frank D Sistare
Jul 25, 2003·Regulatory Toxicology and Pharmacology : RTP·Fanny K Ennever, Lester B Lave
Aug 2, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ronald E Cannon
Aug 20, 2003·Environmental Toxicology and Chemistry·Mark T D CroninAndrew P Worth
Nov 6, 2003·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Hella Lichtenberg-FratéJost Ludwig
Dec 6, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·James MacDonaldJan Willem van der Laan
Feb 26, 2004·Mutagenesis·P A CahillR M Walmsley
Apr 20, 2004·Chemical Research in Toxicology·Jeffrey A KramerRoderick T Bunch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.